3-(4-methoxy-phenyl)-oxazolidin-2-one | 5198-48-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-(4-methoxy-phenyl)-oxazolidin-2-one
• 英文别名: 3-(4-methoxyphenyl)-2-oxazolidinone；N-(4-methoxyphenyl)oxazolidin-2-one；3-(4-methoxyphenyl)-1,3-oxazolidin-2-one
• CAS: 5198-48-1
• 化学式: C₁₀H₁₁NO₃
• 分子量: 193.202
• InChiKey: DXUZFBOIBFYENZ-UHFFFAOYSA-N

物化性质

• 熔点：
  109-111 °C(Solv: ethanol (64-17-5))
• 沸点：
  316.0±21.0 °C(Predicted)
• 密度：
  1.242±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  38.8
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-(4-methoxy-phenyl)-oxazolidin-2-one 在 potassium hydroxide 作用下， 以 乙醇 为溶剂， 生成 2-(4-甲氧基苯胺基)乙醇
  参考文献：
  名称：

  Bis-aryl Urea Derivatives as Potent and Selective LIM Kinase (Limk) Inhibitors

  摘要：

  The discovery/optimization of bis-aryl ureas as Limk inhibitors to obtain high potency and selectivity and appropriate pharmacokinetic properties through systematic SAR studies is reported. Docking studies supported the observed SAR. Optimized Limk inhibitors had high biochemical potency (IC50 < 25 nM), excellent selectivity against ROCK and JNK kinases (>400-fold), potent inhibition of cofilin phosphorylation in A7r5, PC-3, and CEM-SS T cells (IC50 < 1 mu M), and good in vitro and in vivo pharmacokinetic properties. In the profiling against a panel of 61 kinases, compound 18b at 1 mu M inhibited only Limk1 and STK16 with >= 80% inhibition. Compounds 18b and 18f were highly efficient in inhibiting cell-invasion/migration in PC-3 cells. In addition, compound 18w was demonstrated to be effective on reducing intraocular pressure (IOP) on rat eyes. Taken together, these data demonstrated that we had developed a novel class of bis-aryl urea derived potent and selective Limk inhibitors.

  DOI：

  10.1021/jm501680m
• 作为产物：
  描述：

  甲氧苯胺 在 potassium carbonate 作用下， 以 乙腈 为溶剂， 反应 13.0h， 生成 3-(4-methoxy-phenyl)-oxazolidin-2-one
  参考文献：
  名称：

  在亲核条件下通过脱羧开环反应合成 N',N'-二取代 N-芳基-1,2-乙二胺

  摘要：

  : 描述了从苯胺开始，通过 N-aryloxazolidin-2-ones 合成 N',N'-二取代的 N-aryl-1,2-乙二胺的简单实用的合成方法。使用脂肪族仲胺的 N-aryloxazolidin-2-ones 的脱羧开环反应是该过程的关键步骤。还描述了 N-aryloxazolidin-2-ones 的一锅法合成。N',N'-二取代的N-芳基-1,2-乙二胺是生物活性化合物的有用结构单元。

  DOI：

  10.1055/s-2007-983810

文献信息

• 5-HT RECEPTOR MODULATORS
  申请人：Kapadnis Prashant Bhimrao

  公开号：US20130053372A1

  公开（公告）日：2013-02-28

  The invention relates to compounds of formula (I), useful for treating disorders mediated by the 5-hydroxytryptamine (serotonin) receptor IB (5-HT1B), e.g. vascular disorders, cancer and CNS disorders. The invention also provides methods of treating such disorders, and compounds and compositions etc. for their treatment.

  本发明涉及式(I)化合物，用于治疗由5-羟基色胺（血清素）受体IB（5-HT1B）介导的疾病，例如血管疾病、癌症和CNS疾病。本发明还提供了治疗这些疾病的方法，以及用于治疗的化合物和组合物等。
• CuO Nanoparticles Catalyzed C−N, C−O, and C−S Cross-Coupling Reactions: Scope and Mechanism
  作者：Suribabu Jammi、Sekarpandi Sakthivel、Laxmidhar Rout、Tathagata Mukherjee、Santu Mandal、Raja Mitra、Prasenjit Saha、Tharmalingam Punniyamurthy

  DOI：10.1021/jo8024253

  日期：2009.3.6

  nanoparticles have been studied for C−N, C−O, and C−S bond formations via cross-coupling reactions of nitrogen, oxygen, and sulfur nucleophiles with aryl halides. Amides, amines, imidazoles, phenols, alcohols and thiols undergo reactions with aryl iodides in the presence of a base such as KOH, Cs2CO3, and K2CO3 at moderate temperature. The procedure is simple, general, ligand-free, and efficient to afford the

  通过氮，氧和硫亲核试剂与芳基卤化物的交叉偶联反应，已研究了CuO纳米颗粒的C-N，C-O和C-S键形成。酰胺，胺，咪唑，酚，醇和硫醇在中等温度下在碱（例如KOH，Cs 2 CO 3和K 2 CO 3）存在下与芳基碘化物反应。该过程简单，通用，无配体且有效地以高收率提供了交叉偶联的产物。
• Synthesis of Oxazolidinones and Derivatives through Three-Component Fixation of Carbon Dioxide
  作者：Congmin Mei、Yibo Zhao、Qianwei Chen、Changsheng Cao、Guangsheng Pang、Yanhui Shi

  DOI：10.1002/cctc.201800142

  日期：2018.7.19

  three‐component fixation of atmospheric CO2 with readily available 1,2‐dichloroethane and aromatic amine toward oxazolidinones catalyzed by in situ NHC was developed. The reaction occurred in good to excellent yields with good generality and wide functional group tolerance, including challenging steric hindered substituted‐dichloroethane (e.g. 1,2‐dichloropropane and 2,3‐dichlorobutane). The catalytic system

  已经开发了一种有效的三组分固定方法，用现成的NHC催化的1,2-二氯乙烷和芳香族胺直接固定在恶唑烷酮上，以固定大气中的CO 2。该反应以良好的通用性和宽泛的官能团耐受性（包括具有挑战性的位阻取代的二氯乙烷（例如1,2-二氯丙烷和2,3-二氯丁烷））以良好的收率获得了良好的收率。该催化体系对空气和湿气不敏感，即使在约0.3atm的二氧化碳压力下也可获得高产率的恶唑烷酮。机理研究表明，该反应是通过NHC-CO 2原位催化NHC催化的加合物中，1-丁基-3-甲基咪唑-2-羧酸盐为中间体，而氨基氯化物参与反应路径。催化剂可以循环使用至少3次而不会明显降低催化活性。该协议还可以有效地制备六元3-芳基-1,3-氧杂嗪酮-2-一，甚至七元3-芳基-1,3-氧杂氮杂-2-酮，当1,3-二氯丙烷和1时使用了4-二氯丁烷。
• [EN] 5-HT RECEPTOR MODULATORS<br/>[FR] MODULATEURS DU RÉCEPTEUR DE LA 5-HT
  申请人：CAMBRIDGE ENTPR LTD

  公开号：WO2011098776A1

  公开（公告）日：2011-08-18

  The invention relates to compounds of formula (I), useful for treating disorders mediated by the 5-hydroxytryptamine (serotonin) receptor IB (5-HT1B), e.g. vascular disorders, cancer and CNS disorders. The invention also provides methods of treating such disorders, and compounds and compositions etc. for their treatment.

  这项发明涉及到式(I)的化合物，用于治疗通过5-羟色胺（血清素）受体IB（5-HT1B）介导的疾病，例如血管疾病、癌症和中枢神经系统疾病。该发明还提供了治疗这些疾病的方法，以及用于治疗的化合物和组合物等。
• Copper-Catalyzed One-Pot Synthesis of <i>N</i>-Aryl Oxazolidinones from Amino Alcohol Carbamates
  作者：William Mahy、Pawel K. Plucinski、Christopher G. Frost

  DOI：10.1021/ol502322c

  日期：2014.10.3

  sequential intramolecular cyclization of amino alcohol carbamates followed by Cu-catalyzed cross-coupling with aryl iodides under mild conditions has been developed. The reaction occurred in good yields and tolerated aryl iodides containing functionalities such as nitriles, ketones, ethers, and halogens. Heteroaryl iodides and substituted amino alcohol carbamates were also well tolerated.

  已经开发出在氨基甲酸酯氨基甲酸酯的有效顺序分子内环化，然后在温和条件下与芳基碘化物进行铜催化的交叉偶联。该反应以高收率进行，并且可以耐受含有官能团（例如腈，酮，醚和卤素）的芳基碘化物。杂芳基碘化物和取代的氨基醇氨基甲酸酯也被很好地耐受。